PLAU and osteosarcoma: In addition, it has been reported that CA can reduce the activity and protein level of the urokinase-type plasminogen activator, inhibit the migration and invasion ability of osteosarcoma cells, and significantly inhibit pulmonary metastasis of osteosarcoma in mice (Chu et al., 2022).